Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects
Clinical trial NCT04318145 · TERMINATED
Trial details
- NCT number
- NCT04318145
- Sponsor
- Palatin Technologies, Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-12
- Primary completion
- 2023-12-08
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.